Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes.

Graves CL, Li J, LaPato M, Shapiro MR, Glover SC, Wallet MA, Wallet SM.

Front Immunol. 2017 Jan 10;7:679. doi: 10.3389/fimmu.2016.00679.

2.

Antigen-based immunotherapy for autoimmune disease: current status.

Hirsch DL, Ponda P.

Immunotargets Ther. 2014 Dec 16;4:1-11. doi: 10.2147/ITT.S49656. Review.

3.

Trials in the prevention of type 1 diabetes: current and future.

Wherrett DK.

Can J Diabetes. 2014 Aug;38(4):279-84. doi: 10.1016/j.jcjd.2014.05.004. Review.

4.

Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.

Presa M, Ortiz AZ, Garabatos N, Izquierdo C, Rivas EI, Teyton L, Mora C, Serreze D, Stratmann T.

Eur J Immunol. 2013 Nov;43(11):2969-79. doi: 10.1002/eji.201343633.

5.

Clinical potential of antigen-specific therapies in type 1 diabetes.

Coppieters KT, Sehested Hansen B, von Herrath MG.

Rev Diabet Stud. 2012 Winter;9(4):328-37. doi: 10.1900/RDS.2012.9.328. Review.

6.

Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Skyler JS, Pugliese A.

Diabetes Technol Ther. 2013 Jun;15 Suppl 2:S2-13-S2-20. doi: 10.1089/dia.2013.0107.

7.

Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Robert S, Korf H, Gysemans C, Mathieu C.

Islets. 2013 Mar-Apr;5(2):53-66. doi: 10.4161/isl.24785. Review.

8.

Progress in immune-based therapies for type 1 diabetes.

von Herrath M, Peakman M, Roep B.

Clin Exp Immunol. 2013 May;172(2):186-202. doi: 10.1111/cei.12085. Review.

9.

Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.

Staeva TP, Chatenoud L, Insel R, Atkinson MA.

Diabetes. 2013 Jan;62(1):9-17. doi: 10.2337/db12-0562. Review. No abstract available.

10.

Primary and secondary prevention of Type 1 diabetes.

Skyler JS.

Diabet Med. 2013 Feb;30(2):161-9. doi: 10.1111/dme.12100. Review.

11.

Clinical immunologic interventions for the treatment of type 1 diabetes.

Chatenoud L, Warncke K, Ziegler AG.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a007716. doi: 10.1101/cshperspect.a007716. Review.

12.

New and future immunomodulatory therapy in type 1 diabetes.

Tooley JE, Waldron-Lynch F, Herold KC.

Trends Mol Med. 2012 Mar;18(3):173-81. doi: 10.1016/j.molmed.2012.01.001. Review.

13.

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS; Type 1 Diabetes TrialNet GAD Study Group..

Lancet. 2011 Jul 23;378(9788):319-27. doi: 10.1016/S0140-6736(11)60895-7.

14.

Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?

Culina S, Boitard C, Mallone R.

Clin Dev Immunol. 2011;2011:286248. doi: 10.1155/2011/286248.

15.

Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes.

Fourlanos S, Perry C, Gellert SA, Martinuzzi E, Mallone R, Butler J, Colman PG, Harrison LC.

Diabetes. 2011 Apr;60(4):1237-45. doi: 10.2337/db10-1360.

16.

Genetics of type 1 diabetes.

Steck AK, Rewers MJ.

Clin Chem. 2011 Feb;57(2):176-85. doi: 10.1373/clinchem.2010.148221. Review.

17.

T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes.

Babad J, Geliebter A, DiLorenzo TP.

Immunology. 2010 Dec;131(4):459-65. doi: 10.1111/j.1365-2567.2010.03362.x. Review.

18.

Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.

Fousteri G, Chan JR, Zheng Y, Whiting C, Dave A, Bresson D, Croft M, von Herrath M.

Diabetes. 2010 Dec;59(12):3148-58. doi: 10.2337/db10-0561.

19.

Prevention of type 1 diabetes.

Wherrett DK, Daneman D.

Endocrinol Metab Clin North Am. 2009 Dec;38(4):777-90. doi: 10.1016/j.ecl.2009.08.006. Review.

20.

Stem cells and a cure for type 1 diabetes?

Todd JA.

Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15523-4. doi: 10.1073/pnas.0908373106. No abstract available.

Supplemental Content

Support Center